CA-LASERFICHE
16.4.2024 15:01:33 CEST | Business Wire | Press release
Laserfiche — the leading SaaS provider of intelligent content management and business process automation — has announced a number of channel momentum milestones as the organization marks the start of a new era of growth and technology innovation. In 2024, the company is strengthening its partner ecosystem to deliver more ways for organizations to transform the way they manage content, automate workflows and accelerate how business gets done.
“We’ve seen incredible progress across all areas of Laserfiche over the past year, including growth into emerging industries and regions, increased investment into our channel program and resources, and hiring of key leaders,” said Laserfiche CEO Karl Chan. “In 2024, we look forward to building on this momentum, continuing to strengthen our partner ecosystem and bringing even more solutions to market that empower organizations and inspire the world.”
Expanding Global Footprint
Over the past year, Laserfiche saw widespread adoption of digital transformation initiatives in all global regions, with particular growth in EMEA. Testament to this, MBS, a nearly 20-year-old Laserfiche Solution Provider that has customers in 49 countries worldwide, experienced 200% growth in the number of Laserfiche users served. For its success, MBS earned the 2024 Laserfiche International Partner of the Year Award.
“In recent years, we have seen a marked increase in the demand for digital transformation, and Laserfiche is the ideal solution,” said MBS Managing Director Rupert Leaton. “We’re proud to partner with a world-leading vendor for intelligent content management and business process automation, which stays ahead of the curve when it comes to providing innovative solutions for our customers.”
Bolstering Channel Success
In 2024, Laserfiche is building on the momentum with enhancements to its award-winning Solution Provider Program, including new product trainings, sales and marketing resources to support partners. The newly introduced Premier Partner Program increases visibility of highly qualified solution providers and helps to connect them to customers that can best leverage their business and solutions expertise.
Additional new benefits to the Laserfiche Solution Provider Program include a reimagined Winners Circle event to celebrate the top sales achievers annually; open forums for the Laserfiche sales community to share knowledge and strategy; a solution provider track at the annual Laserfiche Empower Conference; and the opportunity to participate in regular advisory councils to influence sales campaigns and resources, product roadmap and more.
Award-Winning Partner Program
“With the growing demand for information management and process automation solutions that also provide enterprise-level information governance, integration and scalability tools, Laserfiche channel partners are uniquely positioned for success,” said Vicki VanValin, vice president of sales at Laserfiche. “We are committed to leading the industry by providing our partners with innovative technology, robust resources and best-in-class service.”
In 2024, The Laserfiche Solution Provider Program earned a 5-star rating in the 2024 Partner Program Guide by CRN, a brand of The Channel Company. The rating is awarded to the companies that go above and beyond in their commitment to nurturing strong, profitable, successful channel partnerships.
Laserfiche’s employees are continually recognized across the channel for their participation and achievements. In February, three of its channel leaders were named to CRN’s 2024 Channel Chief list, including Taylor Grosso, senior director of Global Channels and Alliances, Charles Suzara, associate director – west, and Vicki VanValin, vice president of sales. The prestigious CRN Channel Chiefs list, released annually, recognizes IT vendor and distribution executives who are driving strategy and setting the channel agenda for their companies. In 2023, three others were named to CRN’s Women of the Channel list, including Jann Michishima, partner marketing manager; Nicole Moulton, senior technical trainer; and Kathleen Park, presales manager.
“From getting channel partners the resources they need to ongoing communication and collaboration, Laserfiche’s channel support is among the strongest in the industry,” said Grosso. “Our award-winning channel leadership is dedicated to enabling our partners to achieve their goals, and provide exceptional value to customer organizations around the world.”
Laserfiche will unveil additional enhancements and investments in its channel program in the coming months. To learn more about the Laserfiche Solution Provider Program and the benefits of becoming a partner, visit laserfiche.com/partners.
About Laserfiche
Laserfiche is the leading SaaS provider of intelligent content management and business process automation. Through powerful workflows, electronic forms, document management and analytics, the Laserfiche® platform accelerates how business gets done, enabling leaders to focus on growth across the enterprise.
Laserfiche pioneered the paperless office with enterprise content management. Today, Laserfiche’s cloud-first development approach incorporates innovations in machine learning and AI to enable organizations in more than 80 countries to transform into digital businesses. Customers in every industry — including government, education, financial services, healthcare and manufacturing — use Laserfiche to boost productivity, scale their business and deliver digital-first customer experiences.
Laserfiche employees in offices around the world are committed to the company’s vision of empowering customers and inspiring people to reimagine how technology can transform lives.
Connect with Laserfiche:
Laserfiche Blog | Twitter/X | LinkedIn | Facebook
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240416107538/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
